Arrowhead Publishers
Arrowhead Publishers is a leader in business intelligence and market research reports for the pharmaceutical and biotech industries. Our reports offer readers a blend of information, insight, analysis and forecasting that is essential in today’s ultra-competitive pharmaceutical and biotech markets.
Arrowhead analysts draw upon the most up-to-date information and lend their industry expertise to market reports which assess the state of burgeoning pharmaceutical and biotech markets.
Our reports not only provide the most up-to-date market figures, forecasts, and pipeline data, but offer valuable analysis regarding successes and failures in the ever-competitive healthcare industry. Arrowhead reports blend information and analysis concerning clinical trials, industry trends, and market dynamics to come to determinations about the future of of the pharmaceutical and biotech industries.
Our market reports are designed with the time-sensitive executive in mind and include a large number of graphs and tables which illustrate trends and forecasts that are integral to an understanding of the global healthcare market.
|

|
List of reports from Arrowhead Publishers
|
|
$2,750.00
|
|
|
$2,495.00
|
Lung Cancer Therapeutics Market Outlook and Pipeline Analysis
11/1/2009 | published by: Arrowhead Publishers
... a vital role in the management of lung cancer. Such high level of unmet need ensures the lung cancer market is an attractive commercial opportunity for new drug development. Lung Cancer Therapeutics Market & Pipeline ...
|
more...
|
$2,495.00
|
|
|
$1,495.00
|
Cancer Therapeutics: Market Insight & Pipeline Analysis
8/21/2008 | published by: Arrowhead Publishers
... cancer, prostate cancer, lung cancer, breast cancer, leukemia and non-Hodgkin’s lymphoma. Therapies for other types of cancer are discussed throughout the report, but are limited to the Company Briefs chapter and various tables throughout the ...
|
more...
|
$3,500.00
|
|
|
$2,999.00
|
|
|
$2,999.00
|
|
|
$2,499.00
|
|
|
$2,499.00
|
|
|
$2,999.00
|
|
|
$2,250.00
|
Neurodegenerative Disorder Therapies
1/31/2007 | published by: Arrowhead Publishers
... of aged people, increased life expectancy, unmet clinical needs together with advances in treatments of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease will continue to contribute to the expansion of the global market. This ...
|
more...
|
$2,250.00
|
|
|
$2,250.00
|
|
|
$3,250.00
|
Injectable Drug Delivery: Market Impact and Industry Trends
10/3/2006 | published by: Arrowhead Publishers
... by the rise in patient demand, healthcare and pharma cost containment, as much as by medical and technological advances. The global market for drug delivery technology is worth in excess of US$25 billion in sales. ...
|
more...
|
$1,750.00
|
Rheumatoid Arthritis: Market Trends and R&D Insights
9/20/2006 | published by: Arrowhead Publishers
... reach nearly $13 billion by 2011. Sales of both Remicade and Enbrel continue to grow, while the introduction of Humira in 2003 has been a major stimulus to the market. All three of these products ...
|
more...
|
$1,250.00
|
|
|
$1,500.00
|
|
|
$2,499.00
|
Biotech in Autoimmune and Inflammatory Disease 2006, 2nd Edition
5/1/2006 | published by: Arrowhead Publishers
... with a dearth of invention, patent expirations, and increased generic competition, among other factors undermining their profits. In this environment, the importance of market access strategies, especially in terms of pricing, reimbursement and parallel trade ...
|
more...
|
$2,999.00
|
The Global Drug Delivery Market: Research Trends and Market Outlook
5/1/2006 | published by: Arrowhead Publishers
... patent expiry by providing their reformulation services to pharmaceutical companies, but also by producing their own versions of branded products with improved delivery mechanisms. Thus, post-patent expiry sales can be switched from the ethical manufacturer ...
|
more...
|
$1,999.00
|
Pharmaceutical Pricing, Reimbursement and Parallel Trade 2006
3/1/2006 | published by: Arrowhead Publishers
... with a dearth of invention, patent expirations, and increased generic competition, among other factors undermining their profits. In this environment, the importance of market access strategies, especially in terms of pricing, reimbursement and parallel trade ...
|
more...
|
$1,999.00
|
Cancer Therapeutics 2006: Market Dynamics and R&D Trends
12/1/2005 | published by: Arrowhead Publishers
... this growth are innovative new products, line extensions for existing products, and the coming of age of the biotech industry. Arrowhead Publishers’ new report entitled Cancer Therapeutics 2006: Market Dynamics and R&D Trends examines these ...
|
more...
|
$2,500.00
|
Amgen: Profile, Patents and Pipeline
8/1/2005 | published by: Arrowhead Publishers
... the majority of revenue is based on twenty-year old technology. Can Amgen continue its amazing revenue growth? Or will it fall behind, lacking the small molecule therapeutics that are the mainstay of modern pharmaceuticals? This ...
|
more...
|
$499.00
|
|
|
$1,125.00
|
Pain Therapeutics 2005: Market Dynamics and Outlook
5/1/2005 | published by: Arrowhead Publishers
... from moderate to severe chronic pain worldwide and approximately 50 million Americans suffer with pain. The value of the pharmaceutical market for pain relief reflects this seeming worldwide epidemic of pain, with the overall value ...
|
more...
|
$1,999.00
|
|
Join Alert Me now!Receive bi-weekly email alerts on new market research Sign up today!
|